Zusammenfassung der Master-Thesis von Rossella Belleli Efficiency indicators for new drugs approved by the FDA from 2003 toIn the last decades, the drug development costs have increased while the number of new dru

First Page		Document Content
Date: 2016-03-01 06:14:39 Pharmaceutical sciences Medical research Pharmacology Pharmaceutical industry Clinical research Drug discovery Clinical pharmacology Food and Drug Administration Drug development Prescription Drug User Fee Act Orphan drug		Zusammenfassung der Master-Thesis von Rossella Belleli Efficiency indicators for new drugs approved by the FDA from 2003 toIn the last decades, the drug development costs have increased while the number of new dru Add to Reading List Source URL: intern.public-health-edu.ch Download Document from Source Website File Size: 42,00 KB Share Document on Facebook

	Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT DocID: 1t0K4 - View Document
	Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct DocID: 1sUEh - View Document
	Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA) DocID: 1sUz3 - View Document
	United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight DocID: 1rfHg - View Document
	Best Practices in Developing Proprietary Names for Drugs DocID: 1r8R5 - View Document